Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 6
1982 1
1985 4
1986 3
1987 4
1988 2
1989 5
1990 5
1991 5
1992 3
1993 1
1994 3
1995 3
1996 4
1997 4
1998 5
1999 2
2000 3
2002 5
2003 3
2004 4
2005 2
2006 3
2007 1
2008 2
2010 5
2011 2
2012 1
2013 4
2014 1
2015 3
2016 6
2017 2
2019 4
2020 3
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Results by year
Filters applied: . Clear all
Page 1
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance. Poeschel V, et al. Among authors: frickhofen n. Lancet. 2019 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9. Lancet. 2019. PMID: 31868632 Clinical Trial.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Röllig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Krämer A, Noppeney R, Schäfer-Eckart K, Krause SW, Hänel M, Herbst R, Kunzmann V, Einsele H, Jost E, Brümmendorf TH, Scholl S, Hochhaus A, Neubauer A, Sohlbach K, Fransecky L, Kaufmann M, Niemann D, Schaich M, Frickhofen N, Kiani A, Heits F, Krümpelmann U, Kaiser U, Kullmer J, Wass M, Stölzel F, von Bonin M, Middeke JM, Thiede C, Schetelig J, Berdel WE, Ehninger G, Baldus CD, Müller-Tidow C, Platzbecker U, Serve H, Bornhäuser M. Röllig C, et al. Among authors: frickhofen n. Blood. 2020 Aug 13;136(7):823-830. doi: 10.1182/blood.2019004583. Blood. 2020. PMID: 32496541 Free article.
Aplastic anemia.
Kojima S, Frickhofen N, Deeg HJ, Okamoto S, Marsh J, Teramura M, Bacigalupo A, Mizoguchi H. Kojima S, et al. Among authors: frickhofen n. Int J Hematol. 2005 Dec;82(5):408-11. doi: 10.1532/IJH97.05138. Int J Hematol. 2005. PMID: 16533743 No abstract available.
Acute myeloid leukemia: treatment over 60.
Büchner T, Hiddemann W, Berdel W, Wörmann B, Schoch C, Löffler H, Haferlach T, Schumacher A, Staib P, Balleisen L, Grüneisen A, Rasche H, Aul C, Heyll A, Lengfelder E, Ludwig WD, Maschmeyer G, Eimermacher H, Karow J, Frickhofen N, Hirschmann WD, Sauerland MC; German AML Co-Operative Group. Büchner T, et al. Among authors: frickhofen n. Rev Clin Exp Hematol. 2002 Mar;6(1):46-59; discussion 86-7. doi: 10.1046/j.1468-0734.2002.00059.x. Rev Clin Exp Hematol. 2002. PMID: 12060483 Review.
Late clonal diseases of treated aplastic anemia.
Socié G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A. Socié G, et al. Among authors: frickhofen n. Semin Hematol. 2000 Jan;37(1):91-101. Semin Hematol. 2000. PMID: 10676914 Review.
Persistent parvovirus B19 infections in humans.
Frickhofen N, Young NS. Frickhofen N, et al. Microb Pathog. 1989 Nov;7(5):319-27. doi: 10.1016/0882-4010(89)90035-1. Microb Pathog. 1989. PMID: 2560110 Review. No abstract available.
New diagnostic imaging procedures in Hodgkin's disease.
Bangerter M, Griesshammer M, Binder T, Hafner M, Heimpel H, Reske SN, Frickhofen N. Bangerter M, et al. Among authors: frickhofen n. Ann Oncol. 1996;7 Suppl 4:55-9. doi: 10.1093/annonc/7.suppl_4.s55. Ann Oncol. 1996. PMID: 8836411 Review.
Evaluating Chemotherapy at the End of Life.
Frickhofen N, Maier BO. Frickhofen N, et al. JAMA Oncol. 2016 Jan;2(1):142. doi: 10.1001/jamaoncol.2015.4102. JAMA Oncol. 2016. PMID: 26767554 No abstract available.
115 results